PROFOUND MEDICAL CORP. Operating Income
PROFOUND MEDICAL CORP. (PROF) reported Operating Income of -$11.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- PROFOUND MEDICAL CORP. operating income (loss) for the quarter ending 2026-06-30 was -$11.07M.
- PROFOUND MEDICAL CORP. operating income (loss) for the quarter ending 2026-03-31 was -$8.02M.
- PROFOUND MEDICAL CORP. operating income (loss) for the quarter ending 2025-12-31 was -$7.37M.
- PROFOUND MEDICAL CORP. operating income (loss) for the quarter ending 2025-09-30 was -$8.91M.
- PROFOUND MEDICAL CORP. operating income (loss) for fiscal 2025 was -$41.25M.
- PROFOUND MEDICAL CORP. operating income (loss) for fiscal 2024 was -$33.06M.
- PROFOUND MEDICAL CORP. operating income (loss) for fiscal 2023 was -$28.65M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.07M 10-Q · filed 2026-08-06 | -$19.09M 10-Q · filed 2026-08-06 | -$26.46M derived: sum of 3 quarters · filed 2026-08-06 | -$35.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$8.02M 10-Q · filed 2026-05-07 | -$15.39M derived: sum of 2 quarters · filed 2026-05-07 | -$24.30M derived: sum of 3 quarters · filed 2026-05-07 | -$38.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$16.28M derived: sum of 2 quarters · filed 2026-03-05 | -$30.09M derived: sum of 3 quarters · filed 2026-08-06 | -$41.25M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$8.91M 10-Q · filed 2025-11-13 | -$22.72M derived: sum of 2 quarters · filed 2026-08-06 | -$33.88M 10-Q · filed 2025-11-13 | -$42.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$13.81M 10-Q · filed 2026-08-06 | -$24.97M 10-Q · filed 2026-08-06 | -$33.32M derived: sum of 3 quarters · filed 2026-08-06 | -$42.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$11.17M 10-Q · filed 2026-05-07 | -$19.51M derived: sum of 2 quarters · filed 2026-05-07 | -$28.51M derived: sum of 3 quarters · filed 2026-05-07 | -$36.35M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$17.34M derived: sum of 2 quarters · filed 2026-03-05 | -$25.18M derived: sum of 3 quarters · filed 2026-03-05 | -$33.06M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$9.00M 10-Q · filed 2025-11-13 | -$16.84M derived: sum of 2 quarters · filed 2025-11-13 | -$24.72M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$7.84M 10-Q · filed 2025-08-14 | -$15.72M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$7.88M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$28.65M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |